Skip to main content
Have a personal or library account? Click to login
Disease Knowledge and Treatment Adherence among Adult Patients with Thalassemia: A Cross-sectional Correlational Study Cover

Disease Knowledge and Treatment Adherence among Adult Patients with Thalassemia: A Cross-sectional Correlational Study

By:  and    
Open Access
|Nov 2019

References

  1. 1. Cao A, Galanello R. Beta-Thalassemia. Genet Med. 2010;19(6):61-76. doi:10.1038/gim.2016.17310.1038/gim.2016.173
  2. 2. Al-Kloub MI, Abed MA, Al khawaldeh OA, et al. Predictors of non-adherence to follow-up visits and deferasirox chelation therapy among Jordanian adolescents with thalassemia major. Pediatr Hematol Oncol. 2014;13(7):624-637. doi:10.3109/08880018.2014.939792.10.3109/08880018.2014.939792
  3. 3. Alenazi SA, Ali HW, Alharbi MG, et al. Prevalence of thalassemia and sickle cell disease in Northern border region of Saudi Arabia. Kashmir J Med Sci. 2015;1(1):3-6.
  4. 4. Memish ZA, Owaidah TM, Saeedi MY. Marked regional variations in the prevalence of sickle cell disease and beta-thalassemia in Saudi Arabia: Findings from the premarital screening and genetic counseling program. J Epidemiol Glob Health. 2011;1(1):61-68. doi:10.1016/j.jegh.2011.06.002.10.1016/j.jegh.2011.06.002
  5. 5. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: A systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459-1544. doi:https://doi.org/10.1016/S0140-6736(16)31012-110.1016/S0140-6736(16)31012-1
  6. 6. Alsaeed ES, Farhat GN, Assiri AM, et al. Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011–2015. J Epidemiol Glob Health. 2018;7(1):S41-S47. https://doi.org/10.1016/j.jegh.2017.12.00110.1016/j.jegh.2017.12.001738644229801592
  7. 7. Olwi DI, Merdad LA, Ramadan EK. Thalassemia: a prevalent disease yet unknown term among college students in Saudi Arabia. J Community Genet. 2018;9(3):277-282. doi:10.1007/s12687-017-0351-3.10.1007/s12687-017-0351-3600230529238908
  8. 8. Kingdom of Saudi Arabia-Ministry of Health (MOH). Response to medical advice offered by the healthy marriage program on the rise. Retrieved March 9, 2019, from http://www.moh.gov.sa/en/
  9. 9. Trachtenberg FL, Mednick L, Kwiatkowski JL, et al. Beliefs about chelation among thalassemia patients. Health Qual Life Out. 2012;10:148. doi:10.1186/1477-7525-10-148.10.1186/1477-7525-10-148354584123216870
  10. 10. Burkhart PV, Sabaté E. Adherence to long-term therapies: Evidence for action. J Nurs Scholarsh. 2003;35(3):207.10.1111/j.1547-5069.2003.tb00001.x
  11. 11. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187-1193.
  12. 12. Lemay J, Waheedi M, Al-Sharqawi S, Bayoud T. Medication adherence in chronic illness: Do beliefs about medications play a role? Patient Prefer Adherence. 2018;12:1687-1698. doi:10.2147/PPA.S169236.3023314910.2147/PPA.S169236613027030233149
  13. 13. Pakbaz Z, Treadwell M, Yamashita R, et al. Quality of life in patients with thalassemia intermediary compared to thalassemia major. Ann N Y Acad Sci. 2005;1054:457-461. doi:10.1196/annals.1345.059.10.1196/annals.1345.05916339697
  14. 14. Awwad O, Akour A, Al-Muhaissen S, Morisky D. The influence of patients’ knowledge on adherence to their chronic medications: A cross-sectional study in Jordan. Int J Clin Pharmacol Ther. 2015;37(3):504-510. doi:10.1007/s11096-015-0086-3.10.1007/s11096-015-0086-325708124
  15. 15. Lee YL, Lin DT, Tsai SF. Disease knowledge and treatment adherence among patients with thalassemia major and their mothers in Taiwan. J Clin Nurs. 2009;18(4):529-538. doi:10.1111/j.1365-2702.2007.02150.x.10.1111/j.1365-2702.2007.02150.x19192002
  16. 16. Yang HC, Chen YC, Mao HC, Lin KH. Illness knowledge, social support and self care behavior in adolescents with beta-thalassemia major. Hu Li Yan Jiu=Nursing Research 2001;9:114-124. (Original Work Published in Chinese)
  17. 17. Patton DE, Hughes CM, Cadogan CA, Ryan CA. Theory-based interventions to improve medication adherence in older adults prescribed polypharmacy: A systematic review. Drugs Aging. 2017;34(2):97–113. doi:10.1007/s40266-016-0426-6.10.1007/s40266-016-0426-6529006228025725
  18. 18. Vardaki MA, Philalithis AE, Vlachonokolis I. Factors associated with the attitudes and expectations of patients suffering from beta-thalassemia: A cross-sectional study. Scand J Caring Sci. 2004;18(2):177-187. doi:10.1111/j.1471-6712.2004.00267.x.1514748110.1111/j.1471-6712.2004.00267.x15147481
  19. 19. Nazir SU, Hassali AM, Saleem F, et al. Disease related knowledge, medication adherence and glycaemic control among patients with type 2 diabetes mellitus in Pakistan. Prim Care Diabetes. 2016;10(2):136-141. doi:10.1016/j.pcd.2015.09.004.10.1016/j.pcd.2015.09.00426476867
  20. 20. Patel AP, Parmar PH, Patel RB, et al. Factors influencing beta-thalassemia awareness in Western India. Natl J Community Med, 2016;7(3):193-197.
  21. 21. Colah R, aItalia K, Gorakshakar A. Burden of thalassemia in India: The road map for control. Pediatr Hematol Oncol J. 2017;2(4):79-84. https://doi.org/10.1016/j.phoj.2017.10.00210.1016/j.phoj.2017.10.002
  22. 22. Kourorian Z, Azarkeivan A, Hajibeigi B, et al. The effect of knowledge, attitude and practice on the function of thalassemia patients. Iranian Journal of Blood and Cancer. 2014;6(4):177-181.
  23. 23. Maheen H, Malik F, Siddique B, Qidwai, A. Assessing parental knowledge about thalassemia in a thalassemia center of Karachi, Pakistan. J Genet Couns. 2015; 24(6):945-951. doi:10.1007/s10897-015-9830-z.10.1007/s10897-015-9830-z25843562
  24. 24. Kosaryan M, Vabidshabi K, Siami R, et al. Knowledge, attitudes, and practices of reproductive behaviours in Iranian minor thalassemia couples. Saudi Med J. 2009;30(6):835-839.
  25. 25. Abolghasemi H, Amid A, Zeinali S, et al. Thalassemia in Iran: Epidemiology, prevention, and management. J Pediatr Hematol Oncolo. 2007;29(4):233-238. doi: 10.1097/MPH.0b013e3180437e02.10.1097/MPH.0b013e3180437e0217414565
  26. 26. Hinkle JL, Cheever KH. Brunner and Suddarath text book of medical surgical nursing. 14th Ed. Lippincott Williams & Wilikins: Philadelphia; Pa; 2017.
  27. 27. Pedram M, Zandian K, Keikhaie B, et al. A report on chelating therapy and patient compliance by determination of serum ferritin levels in 243 thalassemia major patients. Iran J Pediatr Society. 2010;2:65-69.
  28. 28. Zeydi AE, Moonaghi HK, Heydari A. Exploring Iranian β-Thalassemia major patients’ perception of barriers and facilitators of adherence to treatment: A qualitative study. Electron Physician. 2017;9(12):6102–6110. doi:10.19082/6102.10.19082/6102584344029560166
  29. 29. Pai ALH, Ostendorf HM. Treatment adherence in adolescents and young adults affected by chronic illness during the health care transition from pediatric to adult health care: A literature review. Child Health Care. 2011;40(1):16–33.10.1080/02739615.2011.537934
DOI: https://doi.org/10.2478/pielxxiw-2019-0014 | Journal eISSN: 2450-646X | Journal ISSN: 1730-1912
Language: English
Page range: 95 - 101
Submitted on: May 8, 2019
Accepted on: Jun 20, 2019
Published online: Nov 12, 2019
Published in print: Jun 1, 2019
Published by: Sciendo
In partnership with: Paradigm Publishing Services

© 2019 Aisha Alnaami, Dhuha Wazqar, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.